OTC Antibody (Center) Blocking Peptide
€363.00
In stock
SKU
AC-BP6928c
Background:
OTC is a mitochondrial matrix enzyme. Missense, nonsense, and frameshift mutations in this enzyme lead to ornithine transcarbamylase deficiency, which causes hyperammonemia.
Other Names:
Ornithine carbamoyltransferase, mitochondrial, Ornithine transcarbamylase, OTCase, OTC
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6928c was selected from the Center region of human OTC. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: OTC (HGNC:8512)
Gene ID: 5009
Primary Accession: P00480
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
OTC is a mitochondrial matrix enzyme. Missense, nonsense, and frameshift mutations in this enzyme lead to ornithine transcarbamylase deficiency, which causes hyperammonemia.
Other Names:
Ornithine carbamoyltransferase, mitochondrial, Ornithine transcarbamylase, OTCase, OTC
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6928c was selected from the Center region of human OTC. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: OTC (HGNC:8512)
Gene ID: 5009
Primary Accession: P00480
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review